We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Approach Helps Predict Neurodegenerative Diseases

By LabMedica International staff writers
Posted on 18 Aug 2010
New studies suggest that neurogenerative diseases such as amyotrophic lateral sclerosis (ALS) can be predicted before symptoms arise.

Scientists described, for the first time, the structure of a protein known as Vps54, one of the four making up the GARP complex of proteins. More...
Using the wobbler mouse as a model, the investigators focused on Vps54, which has a mutation that gives rise to progressive degeneration of motor neurons and to infertility.

Scientists discovered a domino effect in which reduced levels of the mutated protein have a destabilizing effect on the rest of the components of the GARP complex. "The illness develops not only because of the mutation but it may also be due to other mutations or defects that generate reduced levels of the GARP complex or instability therein," explained leader of the study Dr. Aitor Hierro at the Center for Cooperative Research in Biosciences (CIC bioGUNE; Bizkaia, Spain), a nonprofit biomedical research organization.

"The great similarity between the GARP complex proteins of the mouse and amongst humans means that such that a motorneurodegenerative effect in humans due to reduced levels of the GARP mooring complex cannot be discarded. This opens the possibility for studying these levels in humans where, moreover, it will be possible to predict the illness well before the appearance of symptoms," explained Dr Hierro. "It is highly likely that many patients with some motorneurodegenerative disease do not have the same mutation as the wobbler mouse but there does exist the possibility that due to some other reason, some patients may have reduced levels of the GARP complex, a situation which gives rise to the illness."

The GARP complex is the transport network that recycles receptors of acid hydrolases from the lysosomes to the Golgi apparatus. Acid hydrolases in the acidic medium of the lysosomes are activated and digest other proteins.

Subsequently vesicles fuse to discharge their transported content. To avoid the receptors themselves being digested by the acid hydrolases, once the interior of the lysosomes is acidified, these recycle to the Golgi by means of transport vesicles. In this way, the receptors are recycled and reused to transport new acid hydrolases to the lysosomes.

The study concluded that the wobbler phenotype is the consequence of a drastic reduction in the levels of the GARP complex, one that is required to tie up the transport vesicles to the Golgi apparatus. This drop in the levels of the GARP complex thus breaks with the normal functioning of the recycling route of the acid hydrolase receptors to the Golgi apparatus.

The study appeared in the August 14, 2010, edition of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

Related Links:

CIC bioGUNE


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.